Analyzing cancer biology through advanced data integration techniques
Center for comprehensive proteogenomic data analysis
This study is exploring how to better understand cancer by looking at genes and proteins together, and it's creating an easy-to-use tool that helps scientists find new ways to treat different types of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11124915 on NIH RePORTER |
What this research studies
This research focuses on proteogenomics, which combines genomic, transcriptomic, and proteomic data to gain deeper insights into cancer biology. By utilizing next-generation sequencing and mass spectrometry, the project aims to identify potential drug targets and improve understanding of various cancer types. The research will develop a user-friendly, automated platform that simplifies complex data analysis, making it accessible for broader scientific use. This platform will continuously evolve to incorporate new analytical methods as they become available.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with various types of cancer who are interested in contributing to advancements in cancer treatment.
Not a fit: Patients with non-cancerous conditions or those not interested in participating in research may not benefit from this project.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by identifying new drug targets and improving personalized medicine approaches.
How similar studies have performed: Previous research in proteogenomics has shown promising results in enhancing cancer biology understanding and identifying drug targets, indicating a strong potential for success in this approach.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Mani, Denkanikota R — Broad Institute, INC.
- Study coordinator: Mani, Denkanikota R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.